Federal contract award

75FCMC24F0028

THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeOFC OF ACQUISITION AND GRANTS MGMT
NAICS541720 — Research and Development in the Social Sciences and Humanities
PSCAN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Parent award / vehicle75FCMC19D0096
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$9.9M
Current contract value$9.9M
Potential contract value / ceiling$21.0M
Start dateJan 22, 2024
Current end dateJan 21, 2027
Potential end dateApr 21, 2030
Latest award activityJun 29, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 29, 2026P00005$0EOI:: IMPLEMENTING EO 14222 HHS COST EFFICIENCY INITIATIVE(MARCH 19,2025)::EOI MODIFICATION TO DESCOPE THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.
Mar 25, 2026P00004$0EOI:: IMPLEMENTING EO 14222 HHS COST EFFICIENCY INITIATIVE(MARCH 19,2025)::EOI MODIFICATION TO DESCOPE THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.
Aug 14, 2025P00003$-1.3MEOI:: IMPLEMENTING EO 14222 HHS COST EFFICIENCY INITIATIVE(MARCH 19,2025)::EOI MODIFICATION TO DESCOPE THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.
Feb 29, 2024P00002$0THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.
Jan 22, 2024P00001$0THE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.
Jan 17, 20240$11.2MTHE PURPOSE OF THIS TASK ORDER IS TO CONTRACT FOR THE EVALUATION OF THE ENHANCING ONCOLOGY CARE MODEL.

Estimated positioning window

Apr 21, 2029 – Oct 21, 2029

Recompete signal:
45/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 45/100. Available recorded signals: 40 points.

Contract end 2030-04-21 (1274 days from calculation)
+5 points
103 historical awards in this buyer and category group
+15 points
6 recorded award transactions
+10 points
Latest award action: 2026-06-29
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Verify whether remaining options may extend performance beyond the current end date.
  3. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  4. Review the award scope and buyer evidence before making a bid/no-bid decision.